Literature DB >> 8359927

Interleukin-7 enhances antimicrobial activity against Leishmania major in murine macrophages.

A Gessner1, M Vieth, A Will, K Schröppel, M Röllinghoff.   

Abstract

Recently, it has been shown that interleukin-7 (IL-7) is able to induce secretion of cytokines and tumoricidal activity by human monocytes. This study shows that treatment of murine macrophages infected with Leishmania major with IL-7 without any other stimulus reduced the percentage of infected cells, as well as the parasite burden per cell, in a dose-dependent manner to a limited degree (45% reduction of the number of amastigotes per 100 macrophages). Simultaneous treatment of macrophages with gamma interferon and IL-7 led to nearly complete (> 99%) elimination of amastigotes. Addition of anti-tumor necrosis factor alpha or N omega-monomethyl-L-arginine acetate reversed the leishmanicidal effects of IL-7, and production of nitric oxide was induced in the presence of IL-7.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8359927      PMCID: PMC281110          DOI: 10.1128/iai.61.9.4008-4012.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Effect of IL-7 on the growth of fetal thymocytes in culture.

Authors:  J D Watson; P J Morrissey; A E Namen; P J Conlon; M B Widmer
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

2.  Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy.

Authors:  R J Tushinski; I T Oliver; L J Guilbert; P W Tynan; J R Warner; E R Stanley
Journal:  Cell       Date:  1982-01       Impact factor: 41.582

3.  Rat monoclonal antibodies. I. Rapid purification from in vitro culture supernatants.

Authors:  H Bazin; L M Xhurdebise; G Burtonboy; A M Lebacq; L De Clercq; F Cormont
Journal:  J Immunol Methods       Date:  1984-02-10       Impact factor: 2.303

4.  Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.

Authors:  H W Murray; B Y Rubin; C D Rothermel
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

5.  Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.

Authors:  A H Ding; C F Nathan; D J Stuehr
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

6.  Effect of T-lymphocyte suppression on the parasite burden in Leishmania major-infected, genetically susceptible BALB/c mice.

Authors:  W Solbach; K Forberg; M Röllinghoff
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

7.  Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells.

Authors:  R G Goodwin; S Lupton; A Schmierer; K J Hjerrild; R Jerzy; W Clevenger; S Gillis; D Cosman; A E Namen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

8.  Induction of primary anti-viral cytotoxic T cells by in vitro stimulation with short synthetic peptide and interleukin-7.

Authors:  F J Kos; A Müllbacher
Journal:  Eur J Immunol       Date:  1992-12       Impact factor: 5.532

9.  Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells.

Authors:  P J Morrissey; R G Goodwin; R P Nordan; D Anderson; K H Grabstein; D Cosman; J Sims; S Lupton; B Acres; S G Reed
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

10.  Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities.

Authors:  G L Spitalny; E A Havell
Journal:  J Exp Med       Date:  1984-05-01       Impact factor: 14.307

View more
  12 in total

1.  Interleukin-7 in the skin of Schistosoma mansoni-infected mice is associated with a decrease in interferon-gamma production and leads to an aggravation of the disease.

Authors:  I Wolowczuk; M Delacre; O Roye; S L Giannini; C Auriault
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

2.  Prime-boost vaccination with rBCG/rAd35 enhances CD8⁺ cytolytic T-cell responses in lesions from Mycobacterium tuberculosis-infected primates.

Authors:  Sayma Rahman; Isabelle Magalhaes; Jubayer Rahman; Raija K Ahmed; Donata R Sizemore; Charles A Scanga; Frank Weichold; Frank Verreck; Ivanela Kondova; Jerry Sadoff; Rigmor Thorstensson; Mats Spångberg; Mattias Svensson; Jan Andersson; Markus Maeurer; Susanna Brighenti
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

3.  The lymphoid-associated interleukin 7 receptor (IL7R) regulates tissue-resident macrophage development.

Authors:  Gabriel A Leung; Taylor Cool; Clint H Valencia; Atesh Worthington; Anna E Beaudin; E Camilla Forsberg
Journal:  Development       Date:  2019-07-22       Impact factor: 6.868

4.  Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani.

Authors:  P C Melby; Y Z Yang; J Cheng; W Zhao
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

5.  Interleukin-7 or interleukin-15 enhances survival of Mycobacterium tuberculosis-infected mice.

Authors:  M J Maeurer; P Trinder; G Hommel; W Walter; K Freitag; D Atkins; S Störkel
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

6.  Stimulation of B-cell lymphopoiesis by interleukin-7 leads to aggravation of murine leishmaniasis.

Authors:  A Gessner; A Will; M Vieth; K Schröppel; M Röllinghoff
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

7.  The Effect of Naja naja oxiana Snake Venom Against Leishmania tropica Confirmed by Advanced Assays.

Authors:  Iraj Sharifi; Fatemeh Tabatabaie; Saeideh Nikpour; Mahshid Mostafavi; Razieh Tavakoli Oliaee; Fatemeh Sharifi; Zahra Babaei; Elham Jafari; Ehsan Salarkia; Delavar Shahbazzadeh
Journal:  Acta Parasitol       Date:  2020-11-06       Impact factor: 1.440

8.  Unravelling the unsolved paradoxes of cytokine families in host resistance and susceptibility to Leishmania infection.

Authors:  Bernard Ong'ondo Osero; Raphael Taiwo Aruleba; Frank Brombacher; Ramona Hurdayal
Journal:  Cytokine X       Date:  2020-12

Review 9.  Determinants of Unresponsiveness to Treatment in Cutaneous Leishmaniasis: A Focus on Anthroponotic Form Due to Leishmania tropica.

Authors:  Mehdi Bamorovat; Iraj Sharifi; Razieh Tavakoli Oliaee; Abdollah Jafarzadeh; Ahmad Khosravi
Journal:  Front Microbiol       Date:  2021-06-01       Impact factor: 5.640

Review 10.  Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients.

Authors:  Wim Adriaensen; Thomas P C Dorlo; Guido Vanham; Luc Kestens; Paul M Kaye; Johan van Griensven
Journal:  Front Immunol       Date:  2018-01-12       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.